Hemodynamic regulation of tumor necrosis factor-α gene and protein expression in adult feline myocardium

Circulation Research

Volumn 81, Issue 2, 1997, Pages 187-195

  Kapadia, Samir R ^a   Oral, Hakan ^a   Lee, Joseph ^a   Nakano, Masayuki ^a   Taffet, George E ^a   Mann, Douglas L ^a,b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Gene expression; Myocyte; Pressure overload; Tumor necrosis factor

Indexed keywords

MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CAT; CELL MOTION; CONTROLLED STUDY; GENE EXPRESSION REGULATION; HEART FAILURE; HEART MUSCLE CONTRACTILITY; HEART VENTRICLE OVERLOAD; HEMODYNAMICS; HYPERTROPHIC CARDIOMYOPATHY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0030794617     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.81.2.187     Document Type: Article

References (53)

1. Levine B, Kalman J, Mayer L, Fillit HM, Packer M. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med. 1990;223:236-241.
2. McMurray J, Abdullah I, Dargie HJ, Shapiro D. Increased concentrations of tumour necrosis factor in 'cachectic' patients with severe chronic heart failure. Br Heart J. 1991;66:356-358.
3. Dutka DP, Elborn JS, Delamere F, Shale DJ, Morris GK. Tumour necrosis factor-alpha in severe congestive cardiac failure. Br Heart J. 1993;711:141-143.
4. Matsumori A, Yamada T, Suzuki H, Matoba Y, Sasayama S. Increased circulating cytokincs in patients with myocarditis and cardiomyopathy. Br Heart J. 1994;72:561-566.
5. Katz SD, Rao R, Berman JW, Schwarz M, Demopoulos L, Bijou R, LeJemtel TH. Pathophysiological correlates of increased serum tumor necrosis factor in patients with congestive heart failure: relation to nitric oxide-dependent vasodilation in the forearm circulation. Circilation. 1994;90:12-16.
6. Yokoyama T, Vaca L, Rossen RD, Durante W, Hazarika P, Mann DL. Cellular basis for the negative inotropic effects of tumor necrosis factor-alpha in the adult mammalian heart. J Clin Invest. 1993;92:2303-2312.
7. Eichenholz PW, Eichacker PQ, Hoffman WD, Banks SM, Parrillo JE, Damier RL, Natanson C. Tumor necrosis factor challenges in amines: patterns of cardiovascular dysfunction. Am J Physiol. 1992; 263:H668-H675.
8. Suffredini AF, Fromm RE, Parker MM, Brenner M, Kovacs JA, Weslcy RA, Parrillo JE. The cardiovascular response of normal humans to the administration ot endotoxin. N Engl J Med. 1989; 321:280-287.
9. Natanson C, Eichenholz PW, Danner RL, Eichacker W, Hoffman D, Kuo SM, Banks TJ, MacViottie TJ, Parrillo JE. Endotoxin and minor necrosis factor challenges in dogs simulate the cardiovascular profile of human septic shock. J exp Med. 1989;169:823-832.
10. Pagani FD, Baker LS, Hsi C, Knox M, Fink MP, Visner MS. Left ventricular systolic and diastolic dysfunction after infusion of tumor necrosis factor-α in conscious dogs. J Clin Invest. 1992;90:389-398.
11. Hegewisch S, Well HJ, Hossfeld DK. TNF-induced cardiomyopathy. Lancet. 1990;2:294-295.
12. Horgan MJ, Palace GP, Everitt JE, Malik AB. TNF-α release in endotoxemia contributes to neutrophil-dependent pulmonary edema. Am J Physiol. 1993;264:H1161-H1165.
13. Millar AB, Singer M, Meager A, Foley NM, Johnson NM, Rook GA. Tumor necrosis factor in bronchopulmonary secretions of patients with adult respiratory distress syndrome, Lancet. 1989;2: 712-713.
14. Stephens KE, Ishizaka A, Larrick JW, Raffin TA. Tumor necrosis factor causes increased pulmonary permeability and edema. Am Rev Respir Dis. 1988;137:1364-1370.
15. Lo SK, Everitt J, Gu J, Malik AB. Tumor necrosis factor mediates experimental pulmonary edema by ICAM-1 and CD18-dependent mechanisms. J Clin Invest. 1992;89:981-988.
16. Chung MK, Gulick TS, Rotondo RE, Schreiner GF, Lange LG. Mechanism of action of cytokine inhibition of β-adrenergic agonist stimulation of cyclic AMP in rat cardiac myocytes: impairment of signal transaction. Circ Res. 1990;67:753-763.
17. Mann DL, Lee-Jackson D, Yokoyama T. Tumor necrosis factor-alpha and cardiac remodeling. Heart Failure. 1995;166-175.
18. Torre-Amione G, Kapadia S, Lee J, Durand JB, Bies RD, Young JB, Mann DL. Tumor necrosis factor-α and tumor necrosis factor receptors in the failing human heart. Circulation. 1996;93:704-711.
19. Habib FM, Springall DR, Davies GJ, Oakley CM, Yacoub MH, Polak JM. Tumour necrosis factor and inducible nitric oxide synthase in dilated cardiomyopathy. Lancet. 1996;347:1151-1155.
20. Giroir BP, Johnson JH, Brown T, Allen GL, Beutler B. The tissue distribution of tumor necrosis factor biosynthesis during endotoxemia. J Clin Invest. 1992;90:693-698.
21. Kapadia S, Lee JR, Torre-Amione G, Birdsall HH, Ma TS, Mann DL. Tumor necrosis factor gene and protein expression in adult feline myocardium after endotoxin administration. J Clin Invest. 1995;96:1042-1052.
22. Maniatis T, Fritsch EF, Sambrook J. Molecular Cloning: A Labaratory Approach. Cold Spring Harbor, NY: Cold Spring Harbor Press; 1989.
23. Schutze S, Potthoff K, Machleidt T, Berkovic D, Wiegmann K, Kronke M. TNF activates NF-kB by phosphatidylcholine-specific phospholipase C-induced 'acidic' sphingomyelin breakdown. Cell. 1992;71:765-776.
24. Schalasta G, Doppler C. Inhibition of c-fos transcription and phosphorylation of the serum response factor by an inhibitor of phospholipase c-type reactions. Mol Cell Biol. 1990;10:5558-5561.
25. Sadoshima JI, Izumo S. Mechanical stretch rapidly activates multiple signal transduction pathways in cardiac myocytes: potential involvement of an autocrine/paracrine mechanism. EMBO J. 1993;12:1681-1692.
26. Giroir BP, Horton JW, White JD, McIntyre KL, Lin CQ. Inhibition of tumor necrosis factor prevents myocardial dysfunction during hum shock. Am J Physiol. 1994;267:H118-H124.
27. Mann DL, Urabe Y, Kent RL, Vinciguerra S, Cooper G IV. Cellular versus myocardial basis for the contractile dysfunction of hypertrophied myocardium. Circ Res. 1991;68:402-415.
28. Mann DL, Kent RL, Cooper GIV. Load regulation of the properties of adult feline cardiocytes: growth induction by cellular deformation. Circ Res. 1989;64:1079-1090.
29. Mann DL, Kent RL, Parsons B, Cooper G IV. Adrenergic effects on the biology of the adult mammalian carcliocyte. Circulation. 1992;85:790-804.
30. Peterson MB, Lesch M. Protein synthesis and amino acid transport in the isolated rabbit right ventricular papillary muscle. Circ Res. 1972;31:317-327.
31. Tate CA, Taffet GE, Hudson EK, Blaylock SL, McBride RP, Michael LH. Enhanced calcium uptake of cardiac sarcoplasmic reticulum in exercise-trained old rats. Am J Physiol. 1990;258: H431-H435.
32. Paradise N, Schmitter JL, Surmitis JM. Criteria for adequate oxygenation of isometric kitten papillary muscle. Am J Physiol. 1981; 241:H348-H353.
33. Ma TS, Brink PA, Perryman B, Roberts R. Improved quantification with validation of multiple mRNA species by polymerase chain reaction: application to human myocardial creatine kinase M and B. Cardiovasc Res. 1994;28:464-471.
34. Kapadia S, Torre-Amione G, Yokoyama T, Mann DL. Soluble tumor necrosis factor binding proteins modulate the negative inotropic effects of TNF-α in vitro. Am J Physiol. 1995;37:H517-H525.
35. Smith SC, Allen PM. Neutralization of endogenous tumor necrosis factor ameliorates the severity of myosin-induced myocarditis. Circ Res. 1992;70:856-863.
36. Matsumori A, Yamada T, Kawai C. Immunomodulating therapy in viral myocarditis: effects of tumour necrosis factor, interleukin 2 and anti-interleukin-2 receptor antibody in an animal model, Eur Heart J. 1991;12:203-205.
37. Arbustini E, Grasso M, Diegoli M, Bramerio M, Foglieni AS, Albertario M, Matinelli L, Gavazzi A, Goggi C, Campana C, Vigano M. Expression of tumor necrosis factor in human acute cardiac rejection: an immunohistochemical and immunoblotting study. Am J Pathol. 1991;139:709-715.
38. Sakobar A, Horton JD, Bowler K, Manning R, Meager A, Dark JH. Raised levels of tumor-necrosis factor alpha (TNFα) in cardiac transplant patients. Clin Transpl. 1993;7:459-466.
39. Maury CPJ, Teppo AM. Circulating tumour necrosis factor-α (cachectin) in myocardial infarction. J Intern Med. 1989;225: 333-336.
40. Basaran Y, Basaran MM, Babacan KF, Ener B, Okay T, Gok H, Ozdemir M. Serum tumor necrosis factor levels in acute myocardial infarction and unstable angina pectoris. Angiology. 1993;44:332-337.
41. Lefer AM, Tsao P, Aoki N, Palladino MA Jr. Mediation of cardioprotection by transforming arowth factor-β. Science. 1990;249: 61-64.
42. Yokoyama T, Nakano M, Bednarczyk JL, McIntyre BW, Entman ML, Mann DL. Tumor necrosis factor-α provokes a hypertrophic growth response in adult cardiac myocytes. Circulation. 1997;95: 1247-1252.
43. Thaik CM, Calderone A, Takahashi N, Colucci WS. Interleukin-1β modulates the growth and phenotype of neonatal rat cardiac myocytes. J Clin Invest. 1995;96:1093-1099.
44. Dinarello CA. Interleukin-1. In: Thompson A, ed. The Cytokine Handbook. Boston, Mass: Academic Press; 1991:47-82.
45. Mann DL. The effect of tumor necrosis factor-alpha on cardiac structure and function: a tale of two cyokines. J Card Failure. 1996;2:S165-S172.
46. Hughes TK Jr, Smith EM, Chin R, Cadet P, Sinisterra J, Leung MK, Shipp MA, Scharrer B, Stefano GB. Interaction of immunoactive monokines (interleukin 1 and tumor necrosis factor) in the bivalve mollusc mytilus edulis. Proc Natl Acad Sci U S A. 1990;87: 4426-4429.
47. Beck G, Habicht GS. Primitive cytokincs: harbingers of vertebrate defense. Immunol Today. 1991;12:180-183.
48. Nakano M, Knowlton AA, Yokoyama T, Lesslauer W, Mann DL. Tumor necrosis factor-α induced expression of heat shock protein 72 in adult feline cardiac myocytes. Am J Physiol. 1996;270:H1231-H1239.
49. Tsujimoto M, Yokota S, Vilcek J, Weissmann G. Tumor necrosis factor provokes Superoxide anion generation from neutrophils. Biochem Biophys Res Commun. 1986;137:1094-1100.
50. Lloyd SS, Chang AK, Taylor FB, Janzen EG, McCay PB. Free radicals and septic shock in primates: the role of tumor necrosis factor. Free Radic Biol Med. 1993;14:233-242.
51. Krown KA, Page MT, Nguyen C, Zechner D, Gutierrez V, Constock KL, Glembotski CC, Quintana PJE, Sabbadini RA. Tumor necrosis factor alpha-induced apoptosis in cardiac myocytes: involvement of the sphingolipid signaling cascade in cardiac cell death. J Clin Invest. 1996;98:2834-2865.
52. Cheng W, Li B, Kajstura J, Li P, Wolin MS, Sonnenblick EH, Hintze TH, Olivetti G, Anversa P. Stretch-induced programmed myocyte cell death. J Clin Invest. 1995;96:2247-2259.
53. Teiger E, Dam T-V, Richard L, Wisnewsky C, Tea B-S, Gaboury L, Tremblay J, Schwartz K, Hamet P. Apoptosis in pressure overload-induced heart hypertrophy in the rat. J Clin Invest. 1996;97: 2891-2897.